Regulatory Pathway for Licensing Biotherapeutics in Mexico.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 Septiembre 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved...
-
UDIBI
admin_udibi3, , 2023, Sin categorizar, 0
An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS